Kindlin-3 inactivation mediates melanoma agressiveness through crosstalk with the collagen-activated tyrosine kinase receptor DDR1

• C. Reger de Moura,
• B. Louveau,
• F. Jouenne,
• P. Vilquin,
• M. Battistella,
• Y. Bellahsen,
• A. Sadoux,
• S. Menashi,
• M. Mancini,
• N. Dumaz,
• C. Lebbé,
• S. Mourah

Affiliations

C. Reger de Moura

Assistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pharmacology and Tumor Genomics, Paris, France; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France

B. Louveau

Assistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pharmacology and Tumor Genomics, Paris, France; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France

F. Jouenne

Assistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pharmacology and Tumor Genomics, Paris, France; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France

P. Vilquin

Assistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pharmacology and Tumor Genomics, Paris, France

M. Battistella

Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France; Assistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pathology, Paris, France; French Network of Rare Skin Cancers, CARADERM, Paris, France

Y. Bellahsen

Assistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pathology, Paris, France

A. Sadoux

Assistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pharmacology and Tumor Genomics, Paris, France

S. Menashi

Assistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pharmacology and Tumor Genomics, Paris, France; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France

M. Mancini

Assistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pharmacology and Tumor Genomics, Paris, France

N. Dumaz

Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France

C. Lebbé

Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France; Assistance Publique - Hopitaux de Paris, Hopital Saint Louis, Department of Dermatology, Paris, France

S. Mourah

Assistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pharmacology and Tumor Genomics, Paris, France; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France